LexDanaLexDanabeta
Inventor

Wei Zhao

Inventor
Eagleville, PA, US

Overview

46→
Patents
2010–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 46 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes19%
C07KPeptides5%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
C07BGeneral methods of organic chemistry2%
C07CAcyclic or carbocyclic compounds2%
Y02ATechnologies for adaptation to climate change2%
Y02PClimate change mitigation technologies in the production or processing of goods1%
PatentTitleYear
10,836,759Thiazole derivatives useful as mutant IDH1 inhibitors for treating cancer202010,829,481Benzimidazole derivatives as modulators of ROR-gamma202010,829,448Substituted benzoimidazoles as modulators of ROR-g202010,807,980Dihydropyrrolopyridine inhibitors of ROR-gamma202010,689,448Monoclonal antibodies to fibroblast growth factor receptor 2202010,399,976Dihydropyrrolopyridine inhibitors of ROR-gamma201910,301,261Substituted indoles as modulators of ROR-gamma201910,144,715Piperazine derivatives as liver X receptor modulators201810,138,301Monoclonal antibodies to fibroblast growth factor receptor 2201810,087,184Dihydropyrrolopyridine inhibitors of RORg201810,047,085Dihydropyrrolopyridine inhibitors of ROR-gamma20189,868,748'Thiazolopyrrolidine inhibitors of ROR- γ'20189,845,308Isoindoline inhibitors of ROR-gamma20179,834,609Methods of detecting a tumor expressing fibroblast growth factor receptor 220179,814,715'Liver X receptor modulators'20179,796,710'Dihydropyrrolopyridine inhibitors of ROR-gamma'20179,707,232'Liver X receptor modulators'20179,663,515'Dihydropyrrolopyridine inhibitors of ROR-gamma'20179,624,217'Dihydropyrrolopyridine inhibitors of ROR-gamma'20179,481,674'Dihydropyrrolopyridine inhibitors of ROR-gamma'20169,416,135'Liver X receptor modulators'20169,388,190'Liver X receptor modulators'20169,382,324'Monoclonal antibodies to fibroblast growth factor receptor 2'20169,079,861'Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1'20159,006,244'Liver X receptor modulators'20158,927,715'Inhibitors of 11β-hydroxysteroid dehydrogenase type 1'20158,883,778'Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1'20148,835,426'Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1'20148,748,444'Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1'20148,673,899'Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1'20148,603,987'Monoclonal antibodies to fibroblast growth factor receptor 2'20138,580,823'Piperidine renin inhibitors'20138,575,156'Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1'20138,569,292'Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1'20138,487,108'Piperidinyl carbamate intermediates for the synthesis of aspartic protease inhibitors'20138,455,521'Diaminoalkane aspartic protease inhibitors'20138,440,658'Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1'20138,383,629'Inhibitors of 11β-hydroxysteroid dehydrogenase type 1'20138,202,857'1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11β-hydroxysteroid dehydrogenase 1'20128,198,453'Piperidine renin inhibitors'20128,138,178'Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1'20128,106,221'Renin inhibitors'20128,101,723'Monoclonal antibodies to fibroblast growth factor receptor 2'20127,872,028'Diaminopropanol renin inhibitors'20117,858,624'Piperidine and morpholine renin inhibitors'20107,754,737'Diaminoalkane aspartic protease inhibitors'2010

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2010–2018Patents assigned to VITAE PHARMACEUTICALS INC (34)· patent assignee history
2010–2016Based in Eagleville, PA, US· patent location history
2012–2015Patents assigned to CLAREMON DAVID A (17)· patent assignee history
2012–2015Patents assigned to SINGH SURESH B (17)· patent assignee history
2012–2015Patents assigned to ZHAO WEI (17)· patent assignee history
2012–2015Patents assigned to TICE COLIN M (16)· patent assignee history
2012–2020Based in Palo Alto, CA, US· patent location history
2016–2020Based in North Potomac, MD, US· patent location history
2017Based in Germantown, MD, US· patent location history
2020Based in Rockville, MD, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
VITAE PHARMACEUTICALS INC342010–2018
CLAREMON DAVID A172012–2015
SINGH SURESH B172012–2015
ZHAO WEIself172012–2015
TICE COLIN M162012–2015
Locations
LocationPatentsSpan
Eagleville, Pennsylvania, US232010–2016
North Potomac, Maryland, US132016–2020
Palo Alto, California, US62012–2020
Germantown, Maryland, US32017
Rockville, Maryland, US12020